TLR4 and breast cancer: Interestingly, very recently a report has emerged which establishes a role of resistin in inducing EMT and stemness of breast cancer cell, which it accomplishes by being a ligand for toll-like receptor-4 (TLR4), and by stimulating NF-κB-STAT3 signaling34.